University of Southern California
USC Norris Comprehensive Cancer Center

Not logged in...

If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 4P-12-3

MDSC Clinical Assay for Cancer Detection and Monitoring in Prostate Cancer.

Type: Other
Phase: Early Phase I
Status: Open to Accrual
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Alan Epstein, MD,PHD
Other Trial Staff:  Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Kristy Sartor Massopust, Coordinator, Ernesto Duverger, D.M., Yvette Viverette, R.N., Elysse Faye Ballon, Coordinator

Staff may log in to see study documents.

You may participate in this study if:
1Normal men aged 25-39 with no evidence of prostate cancer and stable serum PSA.
2Normal men aged 40 and older with no evidence of prostate cancer and stable serum PSA.
3Men with elevated (>4 ng/ml) and/or rising PSA who will undergo prostate biopsy to rule out prostate cancer.
4Patients with localized prostate cancer who will undergo radical prostatectomy or radiation therapy.
5Patients with metastatic hormone-naïve prostate cancer.
6Patients with newly diagnosed castration-resistant metastatic prostate cancer.

You may not participate in this study if:
1Previous or current history of second malignancy unrelated to prostate cancer; autoimmune disease or immune deficiency, chronic treatment with immunomodulatory therapies (e.g.glucocorticoids); significant trauma, surgery, or infection in the past two weeks

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.